You searched for "laser"
Precision study with the Raypilot ® system now underway
Micropos Medical is a Swedish company developing technology for enhanced radiotherapy cancer treatment. Their Raypilot® System offers accuracy through real-time tumor tracking in prostate cancer radiation treatment. The 2024 Pace-B study showed that SBRT with five sessions is as effective...Vasectomy Find: The UK’s #1 lead generation platform for urology services
Vasectomy Find is transforming how urologists grow their private practices. As the UK’s only dedicated lead generation platform for urology, we connect patients actively searching for private urology services directly with trusted urologists like you. Each enquiry we share is...FRCS Urol Part 2 Viva Preparation: 80+ High-Yield Scenarios and Realistic Exam Practice
SmashUrology has launched a dedicated FRCS Urol Part 2 viva preparation platform to help candidates bridge the gap between urology knowledge and consultant-level performance in the exam setting. The Viva Bank contains over 80 high-yield scenarios covering commonly tested topics...
Urology Unboxed: A guide for aspiring urology residents
Urology Unboxed was a delightful read. It is a comprehensive guide for resident and future resident urologists who seek a structured and in-depth insight into common urological presentations. This easy-to follow handbook encompasses everything that a resident surgeon would require...Poster Presentations for the ERIC Conference 2026
ERIC, The Children’s Bowel & Bladder Charity, are pleased to be hosting this year’s ERIC Conference for healthcare professionals, at The Grand Hotel in Bristol on 12 October 2026. The theme: Together for 35 years: leading change in paediatric bowel...
PARP inhibitors and prostate cancer
The discovery that BRCA1/2-deficient tumour cells are highly sensitive to poly-ADP ribose polymerase (PARP) inhibitors (PARPi) established the foundation of synthetic lethality in metastatic castration-resistant prostate cancer (mCRPC). The TOPARP-A trial confirmed clinical benefit, with PARPi activity largely restricted to...
